The mTOR You Know
Join Lauren Richey, PGY2 Solid Organ Transplant Pharmacy Resident at UCSF, as she reviews CMV prevention strategies in high-risk liver transplant recipients. This episode highlights the CAPSAL trial comparing antiviral prophylaxis and preemptive therapy in CMV D+/R− recipients, reviews key updates from the 2025 International CMV Consensus Guidelines, and discusses practical implications for transplant pharmacy practice.
114 episodes
Comments
0Be the first to comment
Sign up now and become a member of the The mTOR You Know community!